Skip to main content
. 2018 Jun 7;2(3):497–507. doi: 10.1002/rth2.12116

Table 7.

Independent T‐Tests Comparing AF and VTE Patients Within TTR Group

Questionnaire Subscale TTR >75% TTR <50%
AF(n = 187)Mean (SD) VTE(n = 89)Mean (SD) p value AF(n = 164)Mean (SD) VTE(n = 43)Mean (SD) p value
IPQ‐R Timeline Acute Chronic 24.3 (3.8) 25.2 (4.3) 0.092 23.1 (4.1) 23.3 (5.0) 0.889
Timeline Cyclical 8.9 (3.1) 8.0 (3.3) 0.200 10.4 (3.2) 10.3 (3.7) 0.724
Consequences 16.2 (3.9) 16.8 (4.1) 0.283 17.6 (4.4) 18.4 (4.5) 0.374
Personal Control 18.8 (4.4) 18.4 (4.8) 0.595 19.7 (4.0) 19.8 (4.0) 0.927
Treatment Control 16.4 (2.3) 17.1 (2.4) 0.075 16.9 (2.6) 17.1 (3.0) 0.915
Illness Coherence 18.5 (3.9) 18.9 (4.0) 0.529 18.3 (3.9) 17.2 (4.4) 0.119
Emotional Response 14.2 (4.4) 14.5 (5.4) 0.337 15.3 (4.7) 15.8 (5.1) 0.586
Psychological Cause 13.4 (4.1) 11.4 (3.9) 0.001 13.4 (4.0) 13.0 (4.5) 0.245
Risk Factor Cause 17.0 (3.9) 15.3 (3.8) 0.001 17.8 (4.2) 16.5 (5.1) 0.051
Immune Cause 6.4 (1.9) 6.0 (2.1) 0.135 6.8 (1.7) 6.9 (2.5) 0.999
Accidental Cause 4.5 (1.5) 5.2 (1.7) 0.004 4.6 (1.5) 5.6 (1.8) 0.003
BMQ General Harm 19.9 (6.5) 8.9 (2.4) 0.097 23.5 (8.0) 9.7 (2.9) 0.074
General Overuse 11.4 (2.7) 11.2 (2.7) 0.478 10.1 (2.7) 11.8 (3.3) 0.500
Specific Concern 12.0 (3.5) 13.0 (3.6) 0.020 13.9 (3.7) 14.6 (4.4) 0.340
Specific Necessity 17.3 (3.7) 18.5 (3.6) 0.012 16.5 (3.2) 17.8 (3.8) 0.042
ACTS Burdens 19.9 (6.5) 23.5 (8.3) 0.001 23.5 (8.0) 26.3 (9.3) 0.069
Benefits 11.4 (2.7) 11.7 (2.9) 0.704 10.1 (2.7) 11.6 (2.4) 0.004